3rd Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Firm
Client
Income
—
Expenses
$640,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Education related to Hepatitis C issues.

LobbyistCovered position, as disclosed
JOSEPH GROGAN —
DAVID PULLIAM New Health Policy Adv., Leg. Asst, Leg. Corresp & Staff Asst

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Health Issues HCR

Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs. Coverage and reimbursement policy for HCV.

LobbyistCovered position, as disclosed
JOSEPH GROGAN —
DAVID PULLIAM New Health Policy Advis, Gingrey, Leg. Asst & Corresp,Staff Asst

Contacted: Commerce, Dept of (DOC); SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare and Medicaid coverage, access and reimbursement issues for Hepatitis C and HIV products. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.

LobbyistCovered position, as disclosed
JOSEPH GROGAN —
DAVID PULLIAM New Health Adv Gingrey & Leg. Asst, Leg. Corresp & Staff Asst,

Contacted: Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation.

LobbyistCovered position, as disclosed
JOSEPH GROGAN —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; HIV policy issues, HCV issues.

LobbyistCovered position, as disclosed
JOSEPH GROGAN —

Contacted: Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.